DGEN.US Deltagen Inc

Healthcare Biotechnology USA Stocks
- USD
Market cap
-
P/E
-
P/B
-
ROE
-2.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2015.

Is DGEN.US undervalued?

Graham number

The Graham number of Deltagen Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Deltagen Inc fundamental analysis

No fundamental analysis for Deltagen Inc yet.

Deltagen Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Deltagen Inc

Deltagen Inc. provides drug discovery tools and services to the biopharmaceutical industry. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was incorporated in 1997 and is headquartered in San Mateo, California.

Full company profile